Company intelligence / Profile preview

LifeMD Southern Patient Medical Care

Plantation, FL, United States

Ownership: Private
Development stage: Other

Overview

LifeMD operates as a publicly traded telehealth platform with over 725,000 patients served and approximately 275,000 active patient subscribers[1][7]. The company generated $65.7 million in total revenues in Q1 2025, representing 49% year-over-year growth[5].

Therapeutic areas: ImmunologyWomen's HealthOtherNeurologyDermatologyInfectious DiseasesMetabolic DisordersPsychiatryMen's Health
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

Novo Nordisk (Wegovy distribution deal, 2025)Eli Lilly (Zepbound distribution agreement via LillyDirect, March 2025)Medifast (weight management program partnership and $20 million investment, June 2023)Quest Diagnostics and LabCorp (lab testing partnerships)Medicare and select insurance plans

Beyond the preview

Go deeper on LifeMD Southern Patient Medical Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeMD Southern Patient Medical Care.

Explore the full profile